FEB May

439 citations
6 papers · 331 · h-index 6

Impact in

    • HER2/EGFR in Cancer Research
    • Peptidase Inhibition and Analysis
    • Estrogen and related hormone effects

Papers in

    • RNA Research and Splicing 2
    • Molecular Biology Techniques and Applications 2
    • Gene expression and cancer classification 2
    • Genomics and Chromatin Dynamics 2
    • Cancer-related gene regulation 1
    • Estrogen and related hormone effects 6

FEB May

6 papers receiving 320 citations

Peers

FEB May
Comparison fields: 5 of 47
  • Oncology 142
  • Genetics 131
  • Cancer Research 54
  • Immunology 60
  • Immunology and Allergy 16
Replace Moses Adeyanju with:
Moses Adeyanju United States
D. R. Schwartz United States
T. S. Ravikumar United States
Joon T. Park United States
Soo In Bae South Korea
Kiichiro Hashimoto Japan
Teresa Valentina Ranalli Italy
Chris D. Coldren United States
Caroline Choisy-Rossi France
J Torhorst Switzerland
FEB May relative to Moses Adeyanju United States Moses Adeyanju's profile →
Citations per field
00.5×1.5×2.3×
Moses Adeyanju · 1×
Citations per year

Countries citing papers authored by FEB May

Since Specialization
Citations

This map shows the geographic impact of FEB May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by FEB May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites FEB May more than expected).

Fields of papers citing papers by FEB May

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by FEB May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by FEB May. The network helps show where FEB May may publish in the future.

Co-authors

The 8 scholars most cited alongside FEB May, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with FEB May Line = papers co-authored together FEB May links everyone, so they are left out of the graph.

All Works

About FEB May

FEB May is a scholar working on Molecular Biology, Genetics, Pulmonary and Respiratory Medicine, Oncology and Computational Theory and Mathematics, having authored 6 papers that have together received 331 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (6 papers), RNA Research and Splicing (2 papers), Molecular Biology Techniques and Applications (2 papers), Gene expression and cancer classification (2 papers), Genomics and Chromatin Dynamics (2 papers), Cancer-related gene regulation (1 paper), Computational Drug Discovery Methods (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Oncology (142 citations), Genetics (131 citations), Cancer Research (54 citations), Immunology (60 citations) and Immunology and Allergy (16 citations). FEB May has collaborated with scholars based in United Kingdom and Australia. Frequent co-authors include B R Westley, S Nicholson, BR Westley, JA Henry, Colm Hennessy, J R Farndon, Mark D. Carr and T.W.J. Lennard. Their work appears in journals such as British Journal of Cancer and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact